As of December 31, 2025, Baird Medical Investment Holdings Ltd carries a market capitalization of 41.82M, placing it among publicly traded companies globally. Its enterprise value stands at 60.80M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 41.82M |
| Enterprise Value | 60.80M |
Baird Medical Investment Holdings Ltd's next confirmed earnings release is scheduled for March 3, 2027.
| Earnings Date | 3/3/2027 |
As of December 31, 2025, Baird Medical Investment Holdings Ltd has 30.75M shares outstanding.
| Shares Outstanding | 30.75M |
These figures are as of December 31, 2025.
| PB Ratio | 1.33 |
| P/TBV Ratio | 1.34 |
As of December 31, 2025, Baird Medical Investment Holdings Ltd maintains a current ratio of 1.70, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.70 |
| Quick Ratio | 1.32 |
| Debt / Equity | 61.81 |
These figures cover the twelve months ended December 31, 2025.
| Employee Count | 144.50 |
As of the close on November 16, 2026, Baird Medical Investment Holdings Ltd's stock has declined approximately 91.61% over the past 52 weeks. The 50-day moving average sits at 0.59, while the 200-day moving average is 1.28.
| 52-Week Price Change | -91.61% |
| 50-Day Moving Average | 0.59 |
| 200-Day Moving Average | 1.28 |
As of December 31, 2025, Baird Medical Investment Holdings Ltd holds 178,321.00 in cash and equivalents against 19.30M in total debt, resulting in a net debt position of 18.98M. Total book value stands at 31.37M, with working capital of 22.61M providing operational flexibility.
| Cash & Cash Equivalents | 178,321.00 |
| Total Debt | 19.30M |
| Net Debt | 18.98M |
| Equity (Book Value) | 31.37M |
| Book Value Per Share | 1.02 |
| Working Capital | 22.61M |
Already premium?